Modulation of the plasminogen activation system by inflammatory cytokines in human colon carcinoma cells
1996

Inflammatory Cytokines and Colon Cancer Cell Proteolysis

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): C Tran-Thang, EKO Kruithof, H Lahm, W-A Schuster, M Tada, B Sordat

Primary Institution: Swiss Institute for Experimental Cancer Research (ISREC)

Hypothesis

How do inflammatory cytokines affect the plasminogen activation system in human colon carcinoma cells?

Conclusion

Inflammatory cytokines TNF-a and IL-1B increase the production of proteins that regulate tumor cell-mediated plasminogen activation in colon carcinoma cells.

Supporting Evidence

  • TNF-a and IL-1B increased the production of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in several colon carcinoma cell lines.
  • Each cell line responded differently to TNF-a and IL-1B, indicating variability in their response to inflammatory signals.
  • IL-6 had no effect on the plasminogen activation system in any of the cell lines studied.

Takeaway

This study found that certain substances released during inflammation can help cancer cells break down surrounding tissues, which might help them spread.

Methodology

The study involved culturing eight human colon carcinoma cell lines and analyzing their response to inflammatory cytokines using zymography, enzyme immunoassays, and Northern analysis.

Limitations

The responses of the cell lines varied, and the study did not explore the effects of all possible cytokines.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication